Employees and early investors in French health-care startup Doctolib have sold shares in the company worth about €300 million ($345 million), the company said.
Employees and early investors in French health-care startup Doctolib have sold shares in the company worth about €300 million ($345 million), the company said.
An employee of Doctolib at the company's headquarters in Levallois-Perret, France.